|
MRPL10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.070400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.406800E-01 |
| Normal-vs-Stage2 |
5.432200E-02 |
| Normal-vs-Stage3 |
7.214400E-01 |
| Normal-vs-Stage4 |
5.800000E-01 |
| Stage1-vs-Stage2 |
8.878400E-02 |
| Stage1-vs-Stage3 |
7.735000E-01 |
| Stage1-vs-Stage4 |
9.814200E-01 |
| Stage2-vs-Stage3 |
7.974100E-02 |
| Stage2-vs-Stage4 |
1.356350E-01 |
| Stage3-vs-Stage4 |
8.202000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.754600E-01 |
| Normal-vs-AfricanAmerican |
1.953010E-01 |
| Normal-vs-Asian |
1.732370E-01 |
| Caucasian-vs-AfricanAmerican |
4.337400E-01 |
| Caucasian-vs-Asian |
4.115400E-01 |
| AfricanAmerican-vs-Asian |
8.661000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.529200E-01 |
| Normal-vs-Female |
3.537400E-01 |
| Male-vs-Female |
4.999600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.881000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.016800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.134200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.207400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.375000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.383000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.814200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.454600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.078400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.428000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.888800E-01 |
| Classical-VS-Follicular |
7.913600E-01 |
| Classical-VS-Other |
9.918200E-01 |
| Classical-VS-Normal |
2.678000E-01 |
| Tall-VS-Follicular |
3.714800E-01 |
| Tall-VS-Other |
8.197200E-01 |
| Tall-VS-Normal |
9.826800E-01 |
| Follicular-VS-Other |
9.269600E-01 |
| Follicular-VS-Normal |
2.935200E-01 |
| Other-VS-Normal |
8.124000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.209190E-01 |
| Normal-vs-N1 |
2.173200E-01 |
| N0-vs-N1 |
9.400500E-03 |
|
|
